Skip to content
Axcess News – Lifestyle
Author:
BioLargo, Inc.
BioLargo Relaunching CupriDyne(R)-Based Consumer Products – Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
July 13, 2026
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
July 1, 2026
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
May 5, 2026
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
May 4, 2026
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
May 4, 2026
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
April 20, 2026
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
April 1, 2026
BioLargo Reports Annual 2025 Operating and Financial Results
March 7, 2026
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 – 12:00 PM Eastern Time
March 7, 2026
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
March 4, 2026